Quality of life (QOL) companion to CALGB 9840: A phase III study of paclitaxel (P) via weekly 1 hour (hr) versus standard 3 hour infusion every 3 weeks with trastuzumab in the treatment of patients with/without HER-2/neu-overexpressing metastatic breast cancer Meeting Abstract


Authors: Naughton, M. J.; Gu, L.; Wang, X. F.; Seidman, A. D.; Winer, E.; Kornblith, A. B.
Abstract Title: Quality of life (QOL) companion to CALGB 9840: A phase III study of paclitaxel (P) via weekly 1 hour (hr) versus standard 3 hour infusion every 3 weeks with trastuzumab in the treatment of patients with/without HER-2/neu-overexpressing metastatic breast cancer
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 46S
Language: English
ACCESSION: WOS:000239009400182
PROVIDER: wos
DOI: 10.1200/jco.2006.24.18_suppl.674
Notes: --- - Meeting Abstract: 674 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman